Retina Foundation Presents New Data & Conclusions at ARVO 2018
Development of the first patient-reported outcome measure for quality of life and functional vision designed for children with a broad spectrum of eye conditions.
Discovery that children with strabismus (crossed eyes), anisomteropia (unequal focus between the eyes), or both have unsteady fixation when looking with both eyes.
Reported evidence that treatment for both eyes in children with lazy eyes is more effective than patching in rehabilitating the fellow eye as well as the eye with low vision.
Update on the new technologies capable of identifying and quantifying rod function in the retina for patients with inherited retinal disease.
Reported on our evaluation of the safety and efficacy of a new drug for patients with a juvenile macular degeneration known as Stargardt disease.
Related ArticlesJoin Drew Brees and the Retina Foundation for the Third Annual Visionary Luncheon – March 4, 2020 In-Depth Vision Evaluations & Research Updates for Retinal Diseases – Video Update Eight New Volunteers Join Board of Directors Phase III Treatment Trial for Stargardt Disease Enrolls First Patient Retina Foundation Launches Cutting-Edge Artificial Intelligence Project